Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halichondrin B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108948064A reveals a novel acetal-protected route for eribulin intermediates. Discover cost-effective, scalable manufacturing solutions for complex anticancer drug precursors.
Novel process for Eribulin intermediates via efficient Wittig olefination. Reduces synthetic steps and improves stereochemical purity for API manufacturing cost reduction.